We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+22.51%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$125M
AUM Growth
+$785K
Cap. Flow
-$22.1M
Cap. Flow %
-17.66%
Top 10 Hldgs %
56.6%
Holding
62
New
3
Increased
3
Reduced
42
Closed
13

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$1.91M
2
MSFT icon
Microsoft
MSFT
+$1.49M
3
NVO
Novo Nordisk
NVO
+$1.14M
4
HD icon
Home Depot
HD
+$955K
5
JPM icon
JPMorgan Chase
JPM
+$905K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.73%
2 Healthcare 12.97%
3 Technology 11.04%
4 Financials 8.62%
5 Industrials 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
1
Home Depot
HD
$332B
$42.4M 33.93%
169,194
-4,171
-2% -$955K
MSFT icon
2
Microsoft
MSFT
$3.35T
$3.71M 2.97%
18,220
-8,229
-31% -$1.49M
ABT icon
3
Abbott
ABT
$183B
$3.66M 2.93%
40,064
-9,644
-19% -$872K
MCD icon
4
McDonald's
MCD
$191B
$3.37M 2.7%
18,259
-3,897
-18% -$715K
MCHP icon
5
Microchip Technology
MCHP
$40.7B
$2.99M 2.4%
56,846
-11,412
-17% -$513K
ACN icon
6
Accenture
ACN
$99.9B
$2.95M 2.36%
13,751
-3,471
-20% -$656K
UPS icon
7
United Parcel Service
UPS
$89.5B
$2.93M 2.35%
26,371
-6,531
-20% -$652K
JPM icon
8
JPMorgan Chase
JPM
$933B
$2.91M 2.33%
30,944
-9,539
-24% -$905K
NVO
9
Novo Nordisk
NVO
$228B
$2.91M 2.33%
88,784
-35,852
-29% -$1.14M
ADI icon
10
Analog Devices
ADI
$179B
$2.88M 2.31%
23,486
-5,340
-19% -$586K
AJG icon
11
Arthur J. Gallagher & Co
AJG
$65.9B
$2.83M 2.27%
29,079
-6,435
-18% -$570K
PG icon
12
Procter & Gamble
PG
$335B
$2.72M 2.18%
22,733
-4,752
-17% -$554K
AMGN icon
13
Amgen
AMGN
$209B
$2.68M 2.14%
11,344
-3,497
-24% -$798K
CVX icon
14
Chevron
CVX
$383B
$2.54M 2.03%
28,490
-10,108
-26% -$905K
PEP icon
15
PepsiCo
PEP
$191B
$2.46M 1.97%
18,562
-3,590
-16% -$473K
NVS icon
16
Novartis
NVS
$301B
$2.3M 1.84%
26,315
-6,251
-19% -$540K
JNJ icon
17
Johnson & Johnson
JNJ
$617B
$2.23M 1.78%
15,839
-4,055
-20% -$591K
DD icon
18
DuPont de Nemours
DD
$18.7B
$2.21M 1.77%
33,160
+19,834
+149% +$1.16M
RDS.B
19
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$2.13M 1.71%
70,085
-16,890
-19% -$552K
LHX icon
20
L3Harris
LHX
$50.7B
$2.13M 1.71%
12,560
-4,051
-24% -$761K
UN
21
DELISTED
Unilever NV New York Registry Shares
UN
$2.13M 1.7%
39,948
-12,681
-24% -$645K
GILD icon
22
Gilead Sciences
GILD
$163B
$2.13M 1.7%
27,618
-11,164
-29% -$856K
HON icon
23
Honeywell
HON
$76.7B
$2.06M 1.65%
15,103
-4,488
-23% -$594K
CMCSA icon
24
Comcast
CMCSA
$84B
$1.89M 1.51%
48,378
+19,419
+67% +$740K
DEO icon
25
Diageo
DEO
$49.5B
$1.83M 1.46%
13,593
-2,839
-17% -$390K

Similar funds

Brookmont Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Brookmont Capital Management held 62 positions worth $125M, up 0.63% from $124M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Brookmont Capital Management withdrew a net $22.1M in Q2 2020, closing 13 positions and reducing 42 holdings. Its most notable exit was Raytheon Company, an estimated $1.91M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, up from 31% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Brookmont Capital Management opened a new position in RTX Corp worth $1.66M.

  • Brookmont Capital Management's largest Q2 2020 buy was RTX Corp: 27,008 shares worth $1.66M.
  • Brookmont Capital Management added most to DuPont de Nemours in Q2 2020, an estimated $1.16M increase.
  • Brookmont Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $1.49M.
  • Brookmont Capital Management fully exited Raytheon Company in Q2 2020, selling an estimated $1.91M.
  • Brookmont Capital Management's ten largest holdings make up 57% of its $125M portfolio in Q2 2020.
  • Brookmont Capital Management opened 3 new positions and closed 13 in Q2 2020.
  • Brookmont Capital Management's portfolio value rose 0.63% quarter-over-quarter to $125M.

Based on Brookmont Capital Management's 13F filing for Q2 2020, filed 23 Jul 2020.